» Articles » PMID: 18620016

Co-morbidities Associated with Influenza-attributed Mortality, 1994-2000, Canada

Overview
Journal Vaccine
Date 2008 Jul 16
PMID 18620016
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The elderly and persons with specific chronic conditions are known to face elevated morbidity and mortality risks resulting from an influenza infection, and hence are routinely recommended for annual influenza vaccination. However, risk-specific mortality rates have not been established. We estimated age-specific influenza-attributable mortality rates stratified by the presence of chronic conditions and type of residence based on deaths of persons who were admitted to hospital with a respiratory complication captured in our national database. The majority of patients had chronic heart or respiratory conditions (80%) and were admitted from the community (80%). Influenza-attributable mortality rates clearly increase with age for all risk groups. Our influenza-specific estimates identified higher risk ratios for chronic lung or heart disease than have been suggested by other methods. These estimates identify groups most in need of improved vaccines and for whom the use of additional strategies, such as immunization of household contacts or caregivers should be considered.

Citing Articles

A comparative study of influenza surveillance systems and administrative data in England during the 2022-2023 season.

Mellor J, Christie R, Guilder J, Paton R, Elgohari S, Watson C PLOS Glob Public Health. 2024; 4(9):e0003627.

PMID: 39302991 PMC: 11414916. DOI: 10.1371/journal.pgph.0003627.


Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination.

Horswell R, Chu S, Stone A, Fort D, Uwaifo G, Fonseca V BMJ Open Diabetes Res Care. 2024; 12(4).

PMID: 39107077 PMC: 11308876. DOI: 10.1136/bmjdrc-2023-003841.


Modeling the Impacts of Antiviral Prophylaxis Strategies in Mitigating Seasonal Influenza Outbreaks in Nursing Homes.

Morris S, Zipfel C, Peer K, Madewell Z, Brenner S, Garg S Clin Infect Dis. 2023; 78(5):1336-1344.

PMID: 38072652 PMC: 11260992. DOI: 10.1093/cid/ciad764.


Platelet in thrombo-inflammation: Unraveling new therapeutic targets.

Sharma S, Tyagi T, Antoniak S Front Immunol. 2022; 13:1039843.

PMID: 36451834 PMC: 9702553. DOI: 10.3389/fimmu.2022.1039843.


Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly.

Riese P, Trittel S, Akmatov M, May M, Prokein J, Illig T Nat Commun. 2022; 13(1):6894.

PMID: 36371426 PMC: 9653450. DOI: 10.1038/s41467-022-34487-z.